Testing effectiveness (Phase 2)Study completedNCT00352521
What this trial is testing
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma
Who this might be right for
Brain and Central Nervous System Tumors
Duke University 20